Evidence map›Paper›PMID 35338898›Full record

ArticleDrug and alcohol dependence2022

Validity of the DSM-5 tobacco use disorder diagnostics in adults with problematic substance use.

Dvora Shmulewitz, Eliana Greenstein, Malka Stohl, David S Fink, Stephanie Roncone, Claire Walsh, Efrat Aharonovich, Deborah S Hasin

Open access · greenAbstract read
In one paragraph

Article in Drug and alcohol dependence, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Dvora ShmulewitzDepartment of Psychiatry, Columbia University Irving Medical Center, 1051 Riverside Dr, New York, NY 10032, USA; New York State Psychiatric Institute, 1051 Riverside Dr, New York, NY 10032, USA. Electronic address: ds1019@cumc.columbia.edu.
Eliana GreensteinNew York State Psychiatric Institute, 1051 Riverside Dr, New York, NY 10032, USA. Electronic address: eliana.greenstein@nyspi.columbia.edu.
Malka StohlNew York State Psychiatric Institute, 1051 Riverside Dr, New York, NY 10032, USA. Electronic address: malka.schlesinger@nyspi.columbia.edu.
David S FinkNew York State Psychiatric Institute, 1051 Riverside Dr, New York, NY 10032, USA. Electronic address: david.fink@nyspi.columbia.edu.
Stephanie RonconeNew York State Psychiatric Institute, 1051 Riverside Dr, New York, NY 10032, USA. Electronic address: stephanie.roncone@nyspi.columbia.edu.
Claire WalshNew York State Psychiatric Institute, 1051 Riverside Dr, New York, NY 10032, USA. Electronic address: claire.walsh@nyspi.columbia.edu.
Efrat AharonovichNew York State Psychiatric Institute, 1051 Riverside Dr, New York, NY 10032, USA. Electronic address: efrat.aharonovich@nyspi.columbia.edu.
Deborah S HasinDepartment of Psychiatry, Columbia University Irving Medical Center, 1051 Riverside Dr, New York, NY 10032, USA; New York State Psychiatric Institute, 1051 Riverside Dr, New York, NY 10032, USA; Department of Epidemiology, Mailman School of Public Health, Columbia University, 722 W 168th St, New York, NY 10032, USA. Electronic address: deborah.hasin@gmail.com.
New York State Psychiatric InstituteColumbia University Irving Medical Center · US

Funding

Phenotypes for Drug Abuse:Epidemiologic-Genetic ApproachR01DA018652 · NIDA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI HASIN, DEBORAH S · 2004 to 2018
$5.3M
Drinking levels (binge, volume) and alcohol consequences: using national data to identify clinical trial endpoints - Administrative SupplementR01AA025309 · NIAAA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI HASIN, DEBORAH S · 2016 to 2021
$925k
NIAAA NIH HHS R01 AA025309NIDA NIH HHS R01 DA018652
6 · The paper itself

Abstract

backgroundDSM-5 tobacco use disorder (TUD) nosology differs from DSM-IV nicotine dependence (ND) by including craving and DSM-IV abuse criteria, a lower threshold (≥ 2 criteria), and severity levels (mild; moderate; severe). We assessed concurrent and prospective validity of the DSM-5 TUD diagnosis and severity and compared validity with DSM-IV ND diagnosis.

methodsThe sample included U.S. adults with current problematic substance use and past year cigarette smoking (N = 396). Baseline assessment collected information on DSM-IV ND and DSM-5 TUD criteria, smoking-related variables, and psychopathology. Over the following 90 days, electronic daily assessments queried smoking and cigarette craving. Variables expected to be related to TUD were validators: cigarette consumption, cigarette craving scale, Fagerström Test for Nicotine Dependence, and psychiatric disorders. Regression models estimated the association of each validator with DSM-5 TUD and severity levels, and differential association between DSM-5 TUD and DSM-IV ND diagnoses.

resultsDSM-5 TUD and DSM-IV ND were associated with most baseline validators (p-values < 0.05), with significantly stronger associations with DSM-5 TUD for number of days smoked (p = 0.023) and cigarette craving scale (p = 0.007). Baseline DSM-5 TUD and DSM-IV ND predicted smoking and craving on any given day during follow-up, with stronger associations for DSM-5 TUD (association difference [95% CI%]: any smoking, 0.53 [0.27, 0.77]; number of cigarettes smoked, 1.36 [0.89, 1.78]; craving scale, 0.19 [0.09, 0.28]). Validators were associated with TUD severity in a dose-dependent manner.

conclusionDSM-5 TUD diagnostic measures as operationalized here demonstrated concurrent and prospective validity. Inclusion of new criteria, particularly craving, improved validity and clinical relevance.

Indexed as

Substance-Related DisordersTobacco Use DisorderAdultCravingDiagnostic and Statistical Manual of Mental DisordersHumansProspective StudiesConcurrent validityDSM-5Nicotine dependenceProspective validityTobacco use disorder

Identifiers

PMID35338898
PMCPMC9035622
OpenAlexW4221061363

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.